Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Is centralization needed for esophago-gastric cancer patients with low operative risk? a nationwide study

Date

08 Oct 2016

Session

Gastrointestinal tumours, non-colorectal 1

Presenters

Christophe Mariette

Citation

Annals of Oncology (2016) 27 (6): 207-242. 10.1093/annonc/mdw371

Authors

C. Mariette1, C. Gronnier1, A. Pasquer1, F. Renaud2, F. Hec1, A. Gandon1, M. Vanderbeken1, V. Drubay1, G. Caranhac3, G. Piessen1

Author affiliations

  • 1 Dpt Of Digestive And Oncological Surgery, Lille University Hospital, France, 59037 - Lille/FR
  • 2 Dpt Of Pathology, Lille University Hospital, France, 59037 - Lille/FR
  • 3 Hox-com, analytiques, 75000 - Paris/FR
More

Resources

Background

Centralization has been shown to improve POM in esophageal and, to a lesser extent, gastric cancer surgery; however, the benefit of centralization for patients with low operative risk is questionable. The aim of the study was to investigate the impact of center volume on postoperative mortality (POM) according to patient condition.

Methods

All consecutive patients who underwent esophago-gastric cancer surgery between 2010 and 2012 in France were included (n = 11,196). The 30-day POM was compared in terms of the center volume (low: 

Results

Low-volume centers treated 64.2% of patients. A linear decrease in 30-day and 90-day POM was observed with increasing center volume, with rates of 5.7% and 10.2%, 4.3% and 7.9%, 3.3% and 6.7%, and 1.7% and 3.6% in low-, intermediate-, high- and very high-volume centers, respectively (P 

Conclusions

To improve POM, esophago-gastric cancer surgery should be centralized, irrespective of the patient's condition or tumor location.

Clinical trial identification


Legal entity responsible for the study

CHRU Lille

Funding

N/A

Disclosure

All authors have declared no conflicts of interest.

Resources from the same session

Invited discussant LBA25

Presenter: Yelena Janjigian

Session: Gastrointestinal tumours, non-colorectal 1

Resources:

Presentation

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings